Search research articles
Contact Us
Filters
Showing results (391-400 of 533) with videos related to
Page
of 54
Sort By:
Pharmacology, Biochemistry, and Behavior
|
September 1, 1997
Biphasic emetic response of cyclophosphamide in the ferret
R H Wong, L Lao, B M Berman, et al.
Cancer Research
|
January 1, 1970
Joint lethal effects of actinomycin D and radiation in mice
W W Smith, S K Carter, S M Wilson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 1, 1980
Radiotherapy in cooperative clinical trials: Northern California Oncology Group (NCOG) method
E A MacDonald, M L Meurk, G Ray, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
January 1, 1999
Pharmacoeconomic impact of a weight-based heparin protocol
C Bowden, K Carter, K Birtcher, et al.
Cancer
|
November 15, 1983
Chemotherapy of disseminated gastric cancer. A joint effort of the Northern California Oncology Group and the Japanese Gastric Cancer Chemotherapy Group
M A Friedman, M Ogawa, S K Carter, et al.
Journal of the American Veterinary Medical Association
|
July 7, 2001
Osteitis of the axial border of the proximal sesamoid bones in horses: eight cases (1993-1999)
R M Dabareiner, J P Watkins, G K Carter, et al.
Annals of Vascular Surgery
|
May 26, 2015
A pulseless limb poorly predicts an arterial injury in combat trauma
Jacob F Quail, Victoria S McDonald, Kristina K Carter, et al.
The Volta Review
|
April 30, 2011
Word Learning in Children Following Cochlear Implantation
Derek M Houston, Allyson K Carter, David B Pisoni, et al.
Neuroscience
|
January 19, 2016
Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in rats
Y Pang, S Lin, C Wright, et al.
Urology
|
April 11, 2001
Tyrosine kinase inhibitors and signal transduction modulators: Rationale and current status as chemopreventive agents for prostate cancer
R C Bergan, D H Waggle, S K Carter, et al.
Page
of 54
Search research articles
Search
Showing results (391-400 of 533) with videos related to
Sort By:
Page
of 54
Pharmacology, Biochemistry, and Behavior
|
September 1, 1997
Biphasic emetic response of cyclophosphamide in the ferret
R H Wong, L Lao, B M Berman, et al.
Cancer Research
|
January 1, 1970
Joint lethal effects of actinomycin D and radiation in mice
W W Smith, S K Carter, S M Wilson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 1, 1980
Radiotherapy in cooperative clinical trials: Northern California Oncology Group (NCOG) method
E A MacDonald, M L Meurk, G Ray, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
January 1, 1999
Pharmacoeconomic impact of a weight-based heparin protocol
C Bowden, K Carter, K Birtcher, et al.
Cancer
|
November 15, 1983
Chemotherapy of disseminated gastric cancer. A joint effort of the Northern California Oncology Group and the Japanese Gastric Cancer Chemotherapy Group
M A Friedman, M Ogawa, S K Carter, et al.
Journal of the American Veterinary Medical Association
|
July 7, 2001
Osteitis of the axial border of the proximal sesamoid bones in horses: eight cases (1993-1999)
R M Dabareiner, J P Watkins, G K Carter, et al.
Annals of Vascular Surgery
|
May 26, 2015
A pulseless limb poorly predicts an arterial injury in combat trauma
Jacob F Quail, Victoria S McDonald, Kristina K Carter, et al.
The Volta Review
|
April 30, 2011
Word Learning in Children Following Cochlear Implantation
Derek M Houston, Allyson K Carter, David B Pisoni, et al.
Neuroscience
|
January 19, 2016
Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in rats
Y Pang, S Lin, C Wright, et al.
Urology
|
April 11, 2001
Tyrosine kinase inhibitors and signal transduction modulators: Rationale and current status as chemopreventive agents for prostate cancer
R C Bergan, D H Waggle, S K Carter, et al.
Page
of 54